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Hormonal and Genetic Factors Contribute  
to Sex Differences
Obesity and the metabolic syndrome are complex diseases regu-
lated by many genetic and environmental factors. It is well known 
that risk, development and manifestations of obesity-related 
conditions such as diabetes and atherosclerosis are sexually 
dimorphic. Sex differences in obesity are strongly influenced by 
gonadal hormone effects.1,2 However, an additional fundamental 
difference that may contribute to metabolic differences between 
females and males lies within the nucleus of each cell—the XX 
and XY sex chromosome complement.
The sex chromosome complement of female and male cells 
imposes several known genetic differences3 (Fig. 1). For example, 
female cells with an XX chromosome complement never express 
any of the 78 protein-coding genes, nor an unknown number 
of noncoding RNAs, that are present on the Y chromosome. In 
addition, only XX cells undergo the process of transcriptional 
inactivation of one of the two X chromosomes during early devel-
opment as a mechanism to balance gene dosage between males 
and females.4-6 X chromosome inactivation involves the expression 
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Obesity and associated metabolic diseases are sexually 
dimorphic. To provide better diagnosis and treatment for both 
sexes, it is of interest to identify the factors that underlie male/
female differences in obesity. Traditionally, sexual dimorphism 
has been attributed to effects of gonadal hormones, which 
influence numerous metabolic processes. However, the XX/XY 
sex chromosome complement is an additional factor that may 
play a role. Recent data using the four core genotypes mouse 
model have revealed that sex chromosome complement—
independently from gonadal sex—plays a role in adiposity, 
feeding behavior, fatty liver and glucose homeostasis. Potential 
mechanisms for the effects of sex chromosome complement 
include differential gene dosage from X chromosome genes 
that escape inactivation, and distinct genomic imprints on X 
chromosomes inherited from maternal or paternal parents. 
Here we review recent data in mice and humans concerning 
the potential impact of sex chromosome complement on 
obesity and metabolic disease.
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of X chromosome noncoding RNAs, production of high levels 
of histones, widespread chromatin remodeling and chromosome 
condensation, such that XX cells experience a distinct nuclear 
microenvironment during this process.4 Furthermore, whereas 
XY cells inherit only a maternally imprinted X chromosome, 
XX cells carry one X chromosome with maternal imprints and 
another with paternal imprints.5 The random inactivation of 
one X in XX cells therefore could lead to differential expression 
of imprinted genes compared with XY cells. Finally, although 
X-inactivation silences most genes on one X chromosome, some 
genes escape this process and are expressed at a higher level in 
tissues of females than males.6-8
In humans and standard animal models, it has been diffi-
cult to distinguish the contributions of gonadal hormones and 
sex chromosome complement as determinants of obesity, since 
female gonads are virtually always present in combination with 
XX chromosomes, and male gonads with XY chromosomes. To 
tease apart the influence of sex chromosome complement from 
gonadal hormones in obesity and related metabolic traits, we 
have used the four core genotypes mouse model.9,10 In this model, 
the testis-determining gene, Sry, is deleted from the Y chromo-
some and an Sry transgene is inserted into an autosome. Thus, 
the Y chromosome segregates independently from the Sry gene 
and formation of male gonads. As a result, this model allows 
the generation of mice with four different “sexes” on a C57BL/6 
background: XX mice with either male or female gonads, and 
XY mice with either male or female gonads (Fig. 2). In addition, 
we gonadectomized these mice to remove acute gonadal hor-
mone action and uncover the effects of sex chromosome comple-
ment, as well as to detect long-lasting (organizational) effects of 
gonadal hormones.
In our recent study,11 we observed dramatic effects of sex chro-
mosome complement on obesity and metabolism (summarized 
in Fig. 3). Male and female mice with two X chromosomes had 
higher body weight and nearly twice as much body fat than mice 
with one X and one Y chromosome. XX mice also had increased 
food intake during the light (inactive) phase of the circadian 
cycle, potentially contributing to their higher body weight. When 
placed on a high fat diet, XX mice gained weight at an accelerated 
pace, and developed fatty liver and insulin resistance. A potential 
mechanism may be that genes escaping X-inactivation drive these 
differences observed between XX and XY mice. In support of 
this, we observed increased expression of X-inactivation escapees 
in key metabolic tissues (adipose and liver) of XX mice. In this 
article, we discuss these findings in the context of other reported 
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showed a similar degree of steatosis in males and females, but 
greater inflammation in females.18 The different diets used in 
each of these rodent studies make it difficult to make compari-
sons and firm conclusions. However, the results in Chen et al.11 
strongly suggest that sex chromosome complement may be an 
underlying determinant of hepatic steatosis that should be con-
sidered in studies of rodents and humans.
Another typical feature of obesity is insulin resistance. In 
the four core genotypes model, the high fat diet did not alter 
glucose levels, but induced a 2-fold elevation in fasting insulin 
levels in XX mice, but not XY mice.11 Thus, XX chromosome 
complement appears to be a risk factor for insulin resistance 
in this model. Interestingly, studies in humans show that pre-
menopausal women are more insulin sensitive than men.19-21 This 
may be due to the positive effects of estrogen and/or the negative 
effects of androgens on insulin sensitivity.22 Thus, while gonadal 
hormones clearly play a significant role in insulin signaling, our 
work shows that having two X chromosomes may be an addi-
tional genetic determinant, and may become most relevant in a 
hypogonadal state, such as after menopause.
Determinants of Sex Differences in Food Intake  
and Circadian Rhythms
To understand why XX mice accumulate more adipose tissue 
than XY mice, Chen et al.11 assessed energy expenditure, physical 
activity, and food intake at a point when body weights among 
the four genotypes were the same (four weeks post-gonadec-
tomy). No differences were detected in energy expenditure or 
activity among the genotypes, but XX mice exhibited increased 
food intake. This was notable because it occurred prior to their 
sex differences in obesity, metabolic dysregu-
lation, circadian rhythms and food intake.
Sex Chromosomes Influence 
Obesity and Associated Metabolic 
Dysregulation
The sexually dimorphic nature of human 
adipose tissue content and anatomical dis-
tribution has been widely documented and 
reviewed in recent excellent review arti-
cles.12,13 It is well known that pre-menopausal 
women tend to store fat in subcutaneous 
depots, while men tend to store fat in vis-
ceral depots. After menopause, women begin 
to accumulate fat in the viscera, commonly 
associated with increased risk for metabolic 
diseases such as type 2 diabetes, non-alco-
holic fatty liver disease and atherosclerosis. 
These differences in fat distribution have 
been attributed largely to the acute action 
of circulating sex hormones. Studies in the 
four core genotypes mouse model described 
above, however, revealed that sex chromo-
some complement also influences adiposity 
and metabolism.
In gonadally intact mice of the four core genotypes, both 
gonadal sex and sex chromosome complement had effects on 
body weight.11 Gonads were subsequently removed in adulthood, 
thus eliminating acute effects of gonadal hormones. XX mice fed 
a standard mouse chow diet (~5% fat) had almost double the fat 
mass of XY mice, regardless of their original gonadal sex. When 
the mice were fed a high fat diet after gonadectomy, the differ-
ence between XX and XY mice was amplified, with XX mice 
gaining weight more rapidly, and diverging from XY mice after 
only three days on the high fat diet. Analysis of specific fat depots 
revealed that XX mice had larger subcutaneous inguinal adipose 
tissue depots, whereas XY mice had larger gonadal fat pads. This 
result suggests that sex chromosome complement is a contribut-
ing factor to the differences in fat distribution that are observed 
between females and males.
Obesity causes many complications in tissues other than adi-
pose, such as ectopic accumulation of fat in the liver. In addition 
to the increased adiposity in XX mice, a high fat diet promoted 
lipid droplet accumulation in livers of XX mice, whereas XY mice 
were virtually protected.11 This was reflected in increased liver 
mass, increased hepatic triglyceride levels and reduced fatty acid 
oxidation gene expression in XX mice compared with XY mice. 
These results implicate sex chromosome complement as a risk 
factor for fatty liver. Epidemiological data in humans also show 
that sexual dimorphism exists in susceptibility to non-alcoholic 
steatohepatitis, but some populations exhibit increased incidence 
in women, while others report increased incidence in men.14-16 
Data in rodents are also contradictory. Male rats fed a methio-
nine-choline-deficient diet develop more severe hepatic steatosis 
than females,17 whereas C57BL/6J mice fed a high fructose diet 
Figure 1. Genetic and epigenetic consequences of sex chromosome complement. XX cells 
undergo X inactivation, which requires cellular resources to produce histones and non-coding 
RnAs. Some genes escape X inactivation and are expressed at a higher level in XX compared 
with XY cells. Additionally, differential genomic imprinting (silencing) of genes on the X chro-
mosome inherited from maternal and paternal parents can lead to gene dosage differences in 
XX cells and XY cells.
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divergence from XY mice in body weight, and therefore may be 
a causative factor in the subsequent increased adiposity in XX 
mice. It was also notable that the increased food intake occurred 
exclusively during the light phase, during which mice (which 
are nocturnal) have reduced activity and typically consume only 
about 30% of their daily food. The increased food intake during 
the light phase raises the intriguing possibility that sex chromo-
some complement influences circadian regulation.
There is increasing evidence in mice and humans that dis-
ruption in the circadian cycle affects eating patterns and may 
contribute to obesity.23,24 The distribution of caloric intake 
throughout the day is an important factor in human obesity.25 
In particular, eating during the inactive phase of the circadian 
cycle, such as midnight snacking, is associated with weight gain 
and greater risk of the metabolic syndrome.26-28 Genetic disrup-
tion of the circadian cycle by mutation of the mouse Clock gene, 
a central transcriptional regulator of circadian rhythm, causes 
increased feeding during the light (inactive) period and obesity.29 
Furthermore, wild-type mice that eat on a circadian-shifted 
schedule are also prone to obesity. For example, when mice were 
fed equivalent amounts of a high fat diet exclusively during the 
dark phase or exclusively during the light phase, those who ate 
during the light phase gained double the weight, despite similar 
activity levels.30 Additional studies of light-restricted feeding in 
mice have also shown increased weight gain, as well as altered 
metabolic gene expression in fat and liver, and higher respiratory 
exchange ratio, indicating reduced reliance on fatty acid oxida-
tion.31,32 Interestingly, the increased adiposity in XX mice in the 
study by Chen et al.11 was associated with altered metabolic gene 
expression and higher respiratory exchange ratio. The mecha-
nisms for the increased weight gain with disruption of circadian 
rhythm are not well understood, but may depend on a rhythmic 
profile of leptin levels that normally occurs throughout the cir-
cadian cycle.33 It will be interesting to determine whether altered 
rhythmicity of leptin, or perhaps leptin resistance, is present in 
XX compared with XY mice, and whether limitation of feeding 
in XX mice to the dark period may alleviate the increased weight 
gain.
Sexual dimorphism in eating behavior of male and female 
rodents has been described, and gonadal hormones have been 
implicated. Several studies show that food intake and satiety are 
highly regulated by estradiol.34 In gonadally intact female rats, 
a rise in estradiol secretion is followed by a reduction in food 
intake, whereas ovariectomy results in increased food intake. 
Furthermore, estradiol interacts with other satiety signals in the 
central nervous system and in the periphery.34 It has also been 
shown that female rats that have been fasted for 48 h activate 
orexin neurons (which promote feeding) to a greater extent and 
consume more food than males.35 Nevertheless, the data in Chen 
et al.11 showing that gonadectomized mice with XX chromo-
somes eat more than XY mice reveals that additional genetic fac-
tors beyond gonadal hormones also contribute to sex differences 
in food intake and meal patterns. The four core genotypes mouse 
model provides a tool to further dissect the effects of gonadal 
hormones and sex chromosome effects on feeding behavior and 
metabolic disease.
Figure 2. The four core genotypes mouse model. This mouse model 
generates four different “sexes”: mice with female gonads that have 
either XX or XY sex chromosomes, and mice with male gonads that 
have either XX or XY sex chromosomes. Differences between gonadal 
females and gonadal males are attributed to acute or organizational 
gonadal hormone effects, while differences between XX and XY mice 
are attributed to the sex chromosome complement.
Figure 3. Metabolic impact of two X chromosomes. Mice with two X 
chromosomes have a higher food intake during the inactive phase, 
higher body weight and greater adipose tissue content. when placed 
on a high fat diet, these mice exhibit rapid weight gain and develop 
insulin resistance and fatty liver.
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and highlight the mechanism of differential imprinting of the 
X chromosome from the two parents as a potential contributing 
mechanism.
Future Perspectives
Sexual dimorphism is a critical component that affects numer-
ous aspects of metabolism and, hence, susceptibility to metabolic 
disease. The pervasive effect of sex on metabolism is strikingly 
illustrated by a recent metabolomic study of serum from more 
than 3,000 men and women.46 An unbiased analysis of 131 blood 
metabolites (including amino acid, fat and sugar molecules) 
revealed significant concentration differences between males and 
females for 102 of the metabolites. Thus, widespread differences 
in metabolism clearly occur in males and females, and there is a 
need to better understand the nature and origin of these for effec-
tive treatment of metabolic diseases in both sexes.
Studies in humans are valuable, and every effort should be 
made to perform well-designed, sufficiently powered studies of 
both sexes. But such studies will always be limited in their ability 
to provide insight into the underlying mechanisms for sex dif-
ferences, and it is in this realm that animal models are critical. 
The four core genotypes mouse model is one such model and 
is unique in that it allows the discrimination of effects due to 
gonadal sex or sex chromosome complement.10 Based on the ini-
tial identification of sex chromosome effects on adiposity, feeding 
behavior, fatty liver and insulin resistance, we anticipate that this 
model will be useful to provide additional insight into the genetic 
factors and physiological mechanisms involved. As presented 
in Chen et al.,11 genes that escape X chromosome inactivation 
exhibit increased expression levels in tissues such as adipose and 
liver, which may lead to phenotypic differences. In addition to 
the expression of protein coding genes examined thus far, addi-
tional potential players include long non-coding RNAs that are 
known to escape X-inactivation,8 and potentially some of the 70 
microRNAs that are present on the X chromosome, which have 
not been assessed for potential inactivation escape.
A valid question is whether results obtained in a model such 
as the four core genotypes mouse will translate to humans. 
Several factors suggest that they will. The genes on the human 
and mouse X chromosomes are highly conserved, as is the pro-
cess of X chromosome inactivation. Furthermore, the genes 
that are known to escape inactivation in the mouse also escape 
inactivation in humans.47 Additional genes have also been 
shown to escape X-inactivation in humans, suggesting that sex 
chromosome effects may potentially be amplified in humans 
compared with mice.48 And finally, in the mouse studies, sex 
chromosome effects were most apparent in mice that had been 
gonadectomized as adults. Although humans are not typically 
gonadectomized, both women and men experience periods of 
hypogonadal hormone levels, typically beginning in middle age. 
It is likely that the sex chromosome effects observed in mice 
may become more influential in humans with advancing age, 
which is when the majority of individuals develop metabolic 
diseases such as type 2 diabetes and cardiovascular disease. 
It will be interesting to determine the effects on obesity and 
Relevance to Humans
With the increasing longevity of humans and thus a longer time 
spent in a hypogonadal state, it is important to understand non-
hormonal regulators of sexual dimorphism. Chen et al.11 dem-
onstrated that the sex chromosome complement is an important 
determinant of adiposity, fatty liver, and insulin levels in the 
absence of sex hormones. These results in the mouse raise the 
question of whether sex chromosome aneuploidies in humans 
might be instructive about the role of sex chromosomes in meta-
bolic regulation. Human sex chromosome aneuploidies include 
45,X0 females (1/2,500 live female births), 47,XXY males 
(1/500 live male births), 48,XXYY (1/17,000 live male births), 
48,XXXY males (1/50,000 live male births), and 46,XX males 
(1/20,000 live male births, resulting from translocation of the 
SRY gene to the X chromosome).36-38 The rarity of most sex chro-
mosome aneuploidies has made it difficult to assess their effects 
on metabolism. However, some data available for XXY males and 
X0 females indicate higher incidence of metabolic disease than 
the general population, as described below.
Compared with XY males, individuals with Klinefelter syn-
drome (XXY) are more likely to have an atherogenic lipopro-
tein profile, with elevated low density lipoprotein levels, and 
reduced high density lipoprotein levels.39 XXY men may also 
have increased incidence of type 2 diabetes and metabolic syn-
drome, defined as the co-occurrence of visceral obesity, insulin 
resistance and enhanced cardiovascular disease risk.40,41 These 
findings in XXY men are consistent with mouse studies in which 
the presence of two X chromosomes compared with a single X 
was associated with obesity and metabolic dysregulation.11 XXY 
men have lower levels of testicular androgens, which could con-
tribute to the metabolic effects associated with the syndrome, so 
it is unclear which factors are the most important.
Turner syndrome women (X0) tend to have greater fat mass 
when adjusted for body weight than XX females.42,43 X0 women 
may also experience increased risk for type 2 diabetes mellitus 
and heart disease.44 These results appear to contradict the find-
ing in mice that presence of one X chromosome leads to reduced 
adiposity compared with XX mice.11 One factor that potentially 
contributes to increased metabolic dysregulation in Turner syn-
drome women is that they are hypogonadal throughout their 
lifetime. In contrast, in the mouse studies, animals had intact, 
normal gonads until adulthood and therefore may have experi-
enced critical activational and organizational effects of gonadal 
hormones that are metabolically beneficial and not experienced 
by X0 humans. Interestingly, an analysis of body fat and lipid 
levels in a group of Turner syndrome patients showed differences 
depending on the parental origin of the single, normal X chro-
mosome. Individuals that inherited the maternal X chromosome 
had 78% more visceral fat than those carrying an X chromo-
some of paternal origin, and higher triglyceride and low den-
sity lipoprotein cholesterol levels.45 The maternal and paternal 
X chromosomes carry distinct genomic imprints, which silence 
the expression of specific genes and result in different expres-
sion levels. These results dovetail with those in the mouse show-
ing that X chromosome dosage influences metabolic regulation, 
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dysregulated metabolism when gonadectomy is performed in 
four core genotype mice at advanced ages, to better parallel the 
onset of menopause in humans. Moreover, mouse models offer 
considerable advantages for identifying the X gene(s) respon-
sible for the sex chromosome effect, which can then be tested 
in studies of humans. Ultimately, the identification of genes or 
factors that promote or protect against metabolic diseases in a 
sex-specific manner may suggest novel pathways as targets for 
therapeutic intervention.
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